NCT00784602 is a clinical trial in Genital Prolapse, sponsored by Melissa Fischer, MD.

Who is sponsoring NCT00784602?

NCT00784602 is sponsored by Melissa Fischer, MD.

What condition does NCT00784602 study?

NCT00784602 studies Genital Prolapse.

Is NCT00784602 still recruiting?

NCT00784602 is currently terminated. Last updated 3 January 2018.

Last reviewed 2018-01-03 · How we verify

NCT00784602

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes

Terminated Last updated 3 January 2018

What this trial tests

trial in Genital Prolapse in 301 participants. Terminated before completion.

Timeline

29 October 2008

Primary endpoint
29 August 2016

29 August 2016

Quick facts

Lead sponsor	Melissa Fischer, MD
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	301
Start date	29 October 2008
Primary completion	29 August 2016
Estimated completion	29 August 2016
Sites	1 location across United States

Conditions studied

Genital Prolapse — all drugs for Genital Prolapse →

Sponsor

Melissa Fischer, MD

Who can join

21 and older, female only, with Genital Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To prospectively observe the outcomes of surgical prolapse treatment in terms of urinary, bowel, and sexual function, quality of life, patient satisfaction, cost, and achieving patient determined treatment goals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Genital Prolapse

Currently open trials in the same condition.

NCT07306715 — Laparoscopic Pectopexy With and Without Mesh Use for Pelvic Organ Prolapse. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00784602 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Melissa Fischer, MD
Last refreshed: 3 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00784602.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing